Italy put in place a THC limit for foods made from hemp’s grain, giving producers “long-awaited” guidance for bringing products to market. The Italy Ministry of Health set the maximum THC levels at: 2 milligrams per kilogram for flour, seeds and supplements derived from hempseed (grain). 5 milligrams per... Read more
Broad physician adoption of a cannabis-derived epilepsy treatment is boosting sales for the only company with federal permission to sell cannabis products in the United States. London-based GW Pharmaceuticals told investors Monday that it notched $108 million in sales last quarter and $309 million for calendar 2019. The sales figures were... Read more
Prosecutors in Braunschweig, Germany, are seeking prison time against the operators of a retail shop that sold hemp teas. The public prosecutor’s office says the sale of hemp tea is illegal, regardless how low the THC content. The operators of the Hanfbar retail store – Marcel Kaine and Bardia Hatefi –... Read more
(This is an abridged version of a story that appears at Marijuana Business Daily.) A company in Brazil successfully appealed to a court for permission to cultivate hemp on the same day that the Brazilian government decided against creating rules to allow domestic cultivation. The decision could spur other hemp companies... Read more
Local authorities acted correctly by not allowing sales of CBD products that don’t have a “novel food” authorization, a German court decided, confirming an earlier ruling. The “novel food” classification is given by the European Union to products that have not been significantly consumed before 1997. The Gießen Administrative... Read more
A Canadian greenhouse vegetable producer making an expansion into hemp is one of the few companies in the marijuana and hemp industries with a positive consensus earnings estimate for 2019. In this exclusive examination from the Investor Intelligence team at Marijuana Business Daily, analysts note that Village Farms International... Read more
An emerging CBD company plans to take over a Nasdaq-traded pharmaceutical corporation focused on developing cannabinoid pharmaceuticals. Under an agreement announced Tuesday, Heavenly Rx will execute a reverse takeover of Therapix Biosciences. When the proposed deal is complete, the combined entity will be known as Heavenly Rx. Paul Norman,... Read more
Germany will refer to CBD as a “novel food” going forward, following the direction of the European Union (EU), which has ruled that the cannabinoid and products containing cannabidiol can’t be yet be sold without additional safety research. The novel foods distinction is given to products if they have... Read more
A new industry group launching in the United Kingdom on Friday aims to get a reprieve from European rules enforcement by working with food regulators when selling CBD products, a departure from hemp producers who are seeking to undo the rules. The new Association for the Cannabinoid Industry (ACI)... Read more
A strong uptick in doctor prescriptions and coverage from health insurers is being credited for solid quarterly revenues for GW Pharmaceuticals. The London-based firm that makes cannabis-derived CBD medicines reported revenue of $91 million for the third quarter ended Sept. 30, up more than 3,500% from the same period... Read more
